MassMutual Private Wealth & Trust’s Vaxcyte PCVX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$28.4K	Sell	500 -97	-16%	-$5.65K	﹤0.01%	929
2026 Q2	$34.7K	Sell	597 -4	-0.7%	-$217	﹤0.01%	916
2026 Q1	$34.9K	Buy	601 +4	+0.7%	+$217	﹤0.01%	887
2025 Q4	$27.5K	Buy	597 +126	+27%	+$5.64K	﹤0.01%	993
2025 Q3	$17K	Buy	471 +361	+328%	+$12K	﹤0.01%	1187
2025 Q2	$3.58K	Buy	110 +49	+80%	+$1.61K	﹤0.01%	1760
2025 Q1	$2.3K	Sell	61 -16	-21%	-$1.28K	﹤0.01%	1876
2024 Q4	$6.3K	Buy	77 +51	+196%	+$5.06K	﹤0.01%	1441
2024 Q3	$2.97K	Buy	+26	New	+$2.34K	﹤0.01%	1546
2024 Q2	–	Sell	-7	Closed	-$478	–	2210
2024 Q1	$478	Buy	+7	New	+$485	﹤0.01%	1865
2023 Q4	–	Sell	-6	Closed	-$306	–	2052
2023 Q3	$306	Sell	6 -4	-40%	-$197	﹤0.01%	1890
2023 Q2	$499	Buy	+10	New	+$474	﹤0.01%	1779
2021 Q2	–	Sell	-16	Closed	–	–	1270
2021 Q1	$0	Buy	+16	New	+$403	﹤0.01%	1162

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

MassMutual Private Wealth & Trust's PCVX Position: Q3 2026 in Review

MassMutual Private Wealth & Trust reduced its Vaxcyte (PCVX) stake by 16% in Q3 2026, selling an estimated $5.65K and leaving 500 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #929.

MassMutual Private Wealth & Trust first reported a position in PCVX in Q1 2021 and has held it in 13 quarters since. The position peaked at $34.9K in Q1 2026. 167 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

MassMutual Private Wealth & Trust held 500 shares of Vaxcyte worth $28.4K as of Q3 2026.
MassMutual Private Wealth & Trust sold 97 Vaxcyte shares in Q3 2026, an estimated $5.65K.
Vaxcyte made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #929 holding.
MassMutual Private Wealth & Trust first reported a position in Vaxcyte in Q1 2021 and has held it in 13 quarters since.
MassMutual Private Wealth & Trust's Vaxcyte position peaked at $34.9K in Q1 2026.
167 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.